Unique Ingredient Identifier RDH86HJV5Z is listed as a ingredient substance
| RN | 9003-39-8 |
| NCIT | C82263 |
| RXCUI | 1310497 |
| MF | Polymer substance not supported |
UNII RDH86HJV5Z POVIDONE K90 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | TABLET, DELAYED RELEASE | 48 MG |
| AURICULAR (OTIC) | SOLUTION, DROPS | 0.2 % |
| OPHTHALMIC | SOLUTION | 0.3 %W/V |
| OPHTHALMIC | SOLUTION, DROPS | 1.2 % |
| ORAL | CAPSULE | 54.81 MG |
| ORAL | CAPSULE, DELAYED ACTION | 9.29 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 22.82 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 18.8 MG |
| ORAL | CAPSULE, HARD GELATIN | 5.95 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | NA |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 18.8 MG |
| ORAL | GRANULE, FOR SUSPENSION | 32 MG |
| ORAL | SUSPENSION | 0.1 MG/1ML |
| ORAL | TABLET | 78 MG |
| ORAL | TABLET, COATED | 9.77 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 35 MG |
| ORAL | TABLET, DELAYED ACTION | 15 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 4 MG |
| ORAL | TABLET, ENTERIC COATED PARTICLES | 27.6 MG |
| ORAL | TABLET, EXTENDED RELEASE | 78 MG |
| ORAL | TABLET, FILM COATED | 44 MG |
| ORAL | TABLET, SUSTAINED ACTION | 40.8 MG |
| TOPICAL | SOLUTION | 30 MG/1.5ML |
| TOPICAL | SOLUTION | 0.25 %W/W |
| TRANSDERMAL | SOLUTION | 2.5 %W/W |